Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus by Monteith, Andrew J. et al.
Defects in lysosomal maturation facilitate the
activation of innate sensors in systemic
lupus erythematosus
Andrew J. Monteitha,b, SunAh Kanga, Eric Scotta, Kai Hillmana, Zenon Rajfurc,d, Ken Jacobsonc,e, M. Joseph Costelloc,
and Barbara J. Vilena,e,1
aDepartment of Microbiology & Immunology, University of North Carolina, Chapel Hill, NC 27599; bCurriculum in Biochemistry & Biophysics, University of
North Carolina, Chapel Hill, NC 27599; cDepartment of Cell Biology & Physiology, University of North Carolina, Chapel Hill, NC 27599; dDepartment of
Physics, Astronomy, and Applied Computer Science, Institute of Physics, Jagiellonian University, 31-007, Krakow, Poland; and eLineberger Comprehensive
Cancer Center, University of North Carolina, Chapel Hill, NC 27599
Edited by Jason G. Cyster, University of California, San Francisco, CA, and approved March 1, 2016 (received for review July 15, 2015)
Defects in clearing apoptotic debris disrupt tissue and immunolog-
ical homeostasis, leading to autoimmune and inflammatory diseases.
Herein, we report that macrophages from lupus-prone MRL/lpr mice
have impaired lysosomal maturation, resulting in heightened ROS
production and attenuated lysosomal acidification. Impaired lyso-
somal maturation diminishes the ability of lysosomes to degrade
apoptotic debris contained within IgG–immune complexes (IgG-ICs)
and promotes recycling and the accumulation of nuclear self-anti-
gens at the membrane 72 h after internalization. Diminished degra-
dation of IgG-ICs prolongs the intracellular residency of nucleic acids,
leading to the activation of Toll-like receptors. It also promotes phag-
osomal membrane permeabilization, allowing dsDNA and IgG to leak
into the cytosol and activate AIM2 and TRIM21. Collectively, these
events promote the accumulation of nuclear antigens and activate
innate sensors that drive IFNα production and heightened cell death.
These data identify a previously unidentified defect in lysosomal
maturation that provides a mechanism for the chronic activation of
intracellular innate sensors in systemic lupus erythematosus.
systemic lupus erythematosus | Fc gamma receptors |
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The disposal of apoptotic debris is initiated by membranechanges that facilitate the binding of IgM antibodies, acute
phase proteins (C-reactive protein, CRP), and other serum op-
sonins to enhance phagocytosis (1, 2). The disposal of apoptotic
debris is crucial to immune homeostasis because the accumulation
of apoptotic debris (3–5), and the formation of immune complexes
(ICs) (6), have long been associated with systemic lupus erythe-
matosus (SLE). Similarly, impaired clearance of apoptotic bodies
in mice lacking scavenger receptors and complement proteins in-
duces spontaneous autoimmunity (7, 8). The idea that accumulated
apoptotic bodies contribute to SLE is further supported in human
studies describing polymorphisms or decreased expression of scav-
enger receptors, increased expression of FcγRs, or deficiencies in
complement (9–14). Despite these findings, it remains unclear
whether macrophages (MFs) harbor intrinsic defects that impaired
apoptotic cell clearance (15, 16).
Apoptotic debris bound by IgG autoantibodies forms immune
complexes [henceforth referred to as IgG–immune complexes
(IgG-ICs)] that heighten autoantibody production by chronically
stimulating autoreactive B-cell receptors (BCRs) and/or Toll-like
receptors (TLRs) upon delivery of nucleic acids to the endosome
(17, 18). IgG-ICs also bind FcγRs on myeloid cells stimulating
IFNα (19) and BAFF (20) secretion. In addition, activation of cy-
tosolic sensors contributes to the pathology of SLE. Polymorphisms
in the sensor that recognizes cytoplasmic IgG (tripartite motif
containing 21; TRIM21; ref. 21), and heightened expression of
TRIM21 (22) and its regulated genes (22, 23), have been identified
in SLE patients. Further, two cytosolic sensors that recognize
dsDNA (p202 and absent in melanoma 2; AIM2) have been im-
plicated in type 1 interferon (IFN) production in murine lupus (24,
25). The involvement of other cytosolic sensors, including NLRP3/
NLRP1 (26, 27) and STING (28, 29), have been more controver-
sial. Despite the mounting evidence implicating cell debris in the
activation of innate sensors, a mechanism explaining how IgG-ICs
gain access to the cytosol and chronically activate intracellular re-
ceptors/sensors has never been resolved.
Herein, we show that lupus-prone MFs fail to fully mature
lysosomes, causing diminished lysosomal acidification and the
inability to degrade phagocytosed IgG-ICs. As a result, intact
IgG-ICs recycle back to the cell membrane, promoting the ac-
cumulation of surface-bound nuclear antigens. The prolonged
residency of intracellular IgG-ICs in the phagolysosome leads to
membrane permeabilization, allowing dsDNA and IgG to leak
into the cytosol and activate AIM2 and TRIM21. Furthermore,
accumulation of undegraded nucleic acids inside the phagolysosome
leads to the activation of TLR7 and TLR9. The combined activa-
tion of these receptors heightens cell death through inflammasome
formation and leads to IFNα secretion.
Results
IgG-ICs Accumulate in Multiple Murine Models of Autoimmunity. The
accumulation of apoptotic debris has been identified in autoim-
mune diseases other than SLE, including apoptotic beta cells in
diabetes (30), and apoptotic synoviocytes in rheumatoid arthritis
(31). We find that MFs from lupus-prone mice (MRL/lpr and
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NZM2410) accumulate high levels of FcγR-bound IgG-ICs
(Fig. 1) (32). Similarly, SLE patients experiencing active disease
accumulate nuclear antigens on peripheral blood mononuclear
cells (32). Therefore, we assessed whether the accumulation of
IgG-ICs occurs in other autoimmune models by quantifying
the levels of surface IgG and nuclear antigen on MFs from
murine models of diabetes (NOD) and rheumatoid arthritis
(K/BxN). We found that the levels of surface IgG on MFs from
NOD and K/BxN mice with active disease were elevated (Fig.
1C) and had a punctate staining pattern (Fig. S1) similar to
MRL/lprMFs, suggesting aggregated, rather than monomeric, IgG.
Surface Sm levels were slightly elevated on NOD MFs, but absent
on MFs from K/BxN mice, raising the possibility that in other
autoimmune diseases, MFs accumulate aggregated surface IgG
that might be part of immune complexes containing disease-spe-
cific antigens. Because NOD, MRL/lpr, and NZM2410 mice are
genetically unrelated, these findings also suggest that multiple
distinct genetic defects could lead to the accumulation of immune
complexes on the cell surface. Thus, understanding the mech-
anism underlying the accumulation of IgG-ICs on the surface
of MRL/lpr MFs could elucidate a fundamental defect in
autoimmunity.
Lupus-Prone MFs Phagocytose IgG-ICs but Exhibit Defective
Phagolysosome Maturation. In SLE, the accumulation of apopto-
tic debris has been attributed to heightened cell death, impaired
clearance of cell debris, decreased complement, and increased IgG
levels (3–5, 33–36). Whether lupus-prone MFs have intrinsic de-
fects contributing to impaired clearance of apoptotic debris is de-
bated because no mechanism has been defined (15, 16). To identify
how IgG-ICs accumulate, we formed ICs using anti-nucleosome
(PL2.3, IgG2a) bound to apoptotic blebs. The use of apoptotic
blebs and autoantibody allows B6 and MRL/lpr MFs to internalize
physiologically relevant IgG-ICs, and a means to compare phago-
cytosis, intracellular trafficking, and degradation in real time. Using
total internal reflection fluorescence (TIRF) microscopy, we found
B6 and MRL/lprMFs had comparable diffusion coefficients before
internalization and internalized IgG-ICs at similar rates (Fig. 2 A
and B). Therefore, the accumulation of IgG-ICs on the surface of
MRL/lpr MFs is not the result of impaired phagocytosis.
Another possible explanation for accumulation of IgG-ICs on
MRL/lprMFs is improper trafficking to lysosomes. However, cryo-
electron microscopy showed that ∼80% of gold-labeled IgG-ICs
reached lysosomal structures in B6 and MRL/lprMFs within 2 h of
phagocytosis (Fig. 2 C and D). Therefore, intracellular trafficking is
not impaired.
Impaired lysosomal degradation could promote membrane ac-
cumulation of IgG-ICs after internalization and trafficking to ly-
sosomal structures. Lysosomes contain hydrolytic enzymes that
degrade cargo entering the cell through multiple receptors, including
FcγRs (37). Activation of lysosomal enzymes requires the termina-
tion of reactive oxygen species (ROS) production and activation of
the vacuolar H+-ATPase (V-ATPase) to achieve a pH ≤ 5 (38). To
determine the pH of maturing phagosomes, we introduced an
acidotropic ratiometric dye during phagocytosis of IgG-ICs. In B6
MFs, real-time two-photon microscopy identified vesicular fusion
events, resulting in large acidic structures (pH ≤ 4.5) (Fig. 3 A and
B). In MRL/lprMFs, large acidic structures were rarely evident and
vesicles failed to sustain a pH below 5.5. To analyze larger numbers
of MFs, we used ratiometric flow cytometry to quantify the relative
pH of the population. Within 30 min of exposure to IgG-ICs, B6
MFs reduced vesicular pH by 20% then deacidified within 1 h (Fig.
3C). Conversely, MRL/lpr MFs showed an 8% drop in pH. Con-
current with the inability to fully acidify lysosomes, MRL/lpr MFs
exhibited heightened and prolonged production of ROS (Fig. S2).
These results demonstrate that MRL/lpr MFs are functionally im-
paired in lysosomal acidification, but the impairment is not absolute
as seen in lysosomal storage disorders. These findings are consistent
with the idea that antigen processing andMHC presentation remain
partially intact in lupus-prone mice (39, 40).
The impaired acidification and heightened ROS production
suggests that MRL/lpr MFs are not properly maturing the
phagolysosome, thus preventing the degradation of IgG-ICs.
Maturation of the phagolysosome and autophagosome requires
membrane stabilization, achieved through the recruitment of lyso-
some-associated membrane proteins (LAMPs) and light chain 3
(LC3). To assess whether the phagolysosome fully matures, we
quantified the levels of LAMP-1 and LC3A to distinguish autopha-
gosomes (LC3A+, LAMP-1−) and autophagolysosomes (LC3A+,
LAMP-1+) from lysosomes (LC3A−, LAMP1+). Using confocal mi-
croscopy, we found that MRL/lprMFs showed a twofold reduction in
the association of IgG-ICs with LC3A−, LAMP-1+ structures (Fig. 3
D and E). Because IgG-ICs arrive at lysosomal structures (Fig. 2 C
and D), the reduced association of LAMP-1 with vesicles containing
IgG-ICs demonstrates that the impaired acidification of the lyso-
somes is consistent with defective phagolysosome maturation.
Lupus-Prone MFs Recycle IgG-ICs to the Cell Membrane. Damaged
membrane proteins traffic to the lysosome for degradation; how-
ever, impaired degradation promotes their recycling back to the
cell membrane (41, 42). We hypothesized that a similar mechanism
might promote recycling and the accumulation of FcγR-bound
IgG-ICs because they also are targeted to lysosomal structures
following activation (37). To determine whether impaired lyso-
somal degradation promotes accumulation of surface nuclear
antigens, we cocultured MFs with fluorophore-conjugated IgG-
ICs and monitored their localization over time. Greater than
75% of the MFs phagocytosed IgG-ICs and both B6 and MRL/
lpr MFs bound similar levels of IgG-ICs (Fig. 4 A and B). Bound
IgG-ICs were rapidly phagocytosed and evident within vesicular
compartments at 24 h. By 72 h, MFs from the MRL/lpr mice
recycled the IgG-ICs back to the cell membrane, whereas B6
MFs retained them within the cell (Fig. 4 A and B and Fig. S3).
The IgG-ICs appeared to remain intact and bound by FcγRs,
because both the antibody and apoptotic debris colocalized on
the surface of the cell (Fig. S4), and the levels of surface FcγRI
Fig. 1. Autoimmune-prone MFs accumulate IgG-ICs on the cell membrane.
(A and B) CD11b+ cells were purified from spleen and analyzed for surface
Sm and IgG by confocal imaging. (Scale bars: 2.5 μm.) Data represent two
experiments, two mice, 8–10 cells. A representative image of a MF from the
indicated mice (A) and quantification of IgG colocalization with Sm for all cells
imaged (B) is presented. (C) Flow cytometry analysis of surface IgG and Sm on
splenic MFs (CD11b+, CD11c−) relative to B6 IgG [mean fluorescence intensity
(MFI) range = 1.81–7.64] or B6 Sm (MFI range = 1.02–7.55); four experiments,
4–8 mice (B6 ≥ 12 wk, MRL/lpr ≥ 12 wk, NZM2410 = 12–22 wk, NOD ≥ 26 wk;
blood glucose levels > 500 mg/dL, K/BxN ≥ 13 wk; clinical score = 10). Error bars
indicate SEM. Student t test or ANOVA, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
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and IgG on MRL/lpr MFs increased proportionately (32).
Overall, these findings support a model wherein impaired mat-
uration of the lysosome in MRL/lpr MFs diminishes degradation
of IgG-ICs, inducing their recycling back to the membrane.
The levels of nuclear antigen on MFs fromMRL/lprmice lacking
FcγRI (FcγRI−/−MRL/lpr) are decreased 60% compared with cells
from FcγRI+/+MRL/lpr mice, and they remain disease-free (32),
implicating the accumulation of IgG-ICs on FcγRI in SLE. Despite
FcγRI−/−MRL/lpr MFs binding 60% fewer IgG-ICs (Fig. 4 A and
B), they remain impaired in lysosomal acidification and recycle
internalized IgG-ICs. Therefore, FcγRI is not the only receptor that
recycles IgG-ICs, and loss of FcγRI decreases the amount of IgG-
ICs that are internalized.
To assess whether recycling is unique to ICs containing apoptotic
debris, we bound anti-LPS (IgG2b) to gentamicin-killed Escherichia
coli (E. coli-ICs). Although MRL/lpr MFs phagocytosed fewer E.
coli-ICs (Fig. 4C), 72 h following phagocytosis, the levels of LPS on
the cell surface increased threefold compared with those on B6
MFs (Fig. 4D). These findings indicate that E. coli-ICs also fail to
be degraded by MRL/lpr MFs. To assess whether all ICs were
recycled in MRL/lpr MFs, we cultured MFs with ICs formed by
binding TNP20KLH to anti-TNP IgG2a (TNP-ICs). Surprisingly,
both MRL/lpr and B6 MFs phagocytosed and degraded the TNP-
ICs (Fig. 4E, Right), unlike IgG-ICs (Fig. 4E, Left). These data
demonstrate that MRL/lpr MFs degrade some IgG-ICs, and that
recycling is not unique to ICs containing apoptotic debris.
To assess whether impaired lysosomal acidification is sufficient
to induce recycling of IgG-ICs, we inhibited lysosome function in
B6 MFs and assessed whether this induced IgG-ICs to recycle.
Concanamycin A prevents acidification and degradation of phago-
cytosed cargo by specifically inhibiting the lysosomal V-ATPase. B6
MFs treated with concanamycin A recycled IgG-ICs at levels similar
as MRL/lprMFs (Fig. 4F). Thus, diminished lysosomal acidification
is sufficient to promote recycling and accumulation of IgG-ICs.
Impaired Lysosomal Maturation Permeabilizes the Phagolysosomal
Membrane Allowing dsDNA and IgG To Leak into the Cytosol. Stud-
ies of microbial pathogens have shown that some intracellular
bacteria prevent phagosomal maturation, resulting in bacterial
antigens accessing the cytosol (43, 44). In a similar manner,
impaired lysosomal maturation in MRL/lpr MFs might allow
antigens from IgG-ICs to gain access to the cytosol and activate
innate sensors. Therefore, we selected two cytosolic sensors
(AIM2 and TRIM21) that recognize different components from
IgG-ICs (dsDNA and IgG) to determine whether the inability to
mature the lysosome permeabilizes the phagolysosome, allowing
antigens to leak into the cytosol. To assess whether nuclear anti-
gens gained access to the cytosol, we stimulated B6 and MRL/lpr
MFs with IgG-ICs containing fluorescent dsDNA. Immunopre-
cipitation of AIM2 from B6 and MRL/lpr MFs showed equal
levels of AIM2 protein (Fig. 5A). Despite equal amounts of protein,
MRL/lpr MFs had a 2.5-fold increase in the amount of dsDNA
bound to AIM2 compared with B6 (Fig. 5B). In contrast, AIM2
from FcγRI−/−MRL/lpr MFs bound the same level of dsDNA as
B6. These findings suggest that although FcγRI−/−MRL/lpr MFs
recycle IgG-ICs (Fig. 4 A and B), they leak fewer antigens into the
cytosol, possibily as a consequence of decreased internalization of
IgG-ICs, or because FcγR-specific signals are necessary to per-
meabilize the phagolysosome.
AIM2 initiates inflammasome formation by recruiting procas-
pase-1 through the linker molecule ASC resulting in the cleavage
and activation of caspase-1 (24). To assess whether phagocytosis of
IgG-ICs by MFs induces inflammasome formation, we quantified
active caspase-1, and enumerated cytosolic ASC foci (Fig. 5 C and
Fig. 2. MRL/lprMFs phagocytose and traffic IgG-ICs to lysosomal structures.
(A and B) Bone marrow-derived macrophages (BMMFs) were cultured with
Alexa488-labeled IgG-ICs and examined over time by TIRF microscopy; four
experiments, four mice, cells = 9–12, n = 47–48. The mean squared dis-
placement (MSD) was calculated by tracking the displacement of IgG-ICs on
the surface of the cell until the IgG-IC left the imaging plane (phagocytosis).
(A) Each point is the average MSD of 4–7 IgG-ICs from two to four cells in the
imaging plane. (B) A representative time series of IgG-ICs on the surface of a
MRL/lprMF (arrows) is presented. (C and D) BMMFs were cultured with gold-
labeled IgG-ICs for 2 h and examined by cryo-electron microscopy; two ex-
periments, two mice, 12–15 cells. A representative image of a MF from the
indicated mice (C ) and the subcellular localization of IgG-ICs in each cell
and quantified for all cells imaged (D) is presented. IgG-ICs were found in
phagosomes (single membrane, electron light), lysosomes (single membrane,
electron dense), autophagosomes (double membrane), and on the cell
membrane. Error bars = SEM. Student t test, *P ≤ 0.05, **P ≤ 0.01, ***P ≤
0.001. (Scale bars: 1 μm.)
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D). In the resting state, the number of MRL/lprMFs containing ASC
foci was consistently elevated compared B6 and FcγRI−/−MRL/lpr
MFs, but this difference was not statistically significant. After
culturing the MFs for 4 h with IgG-ICs, ∼40% of the MRL/lpr
MFs exhibited ASC foci compared with 20% in B6 and FcγRI−/−
MRL/lprMFs (Fig. 5D). This finding was consistent with diminished
binding of dsDNA to AIM2 in B6 and FcγRI−/−MRL/lprMFs (Fig. 5
A and B). In MRL/lpr MFs, heightened formation of ASC foci co-
incided with a 4.5-fold increase in active caspase-1 compared with
either B6 or FcγRI−/−MRL/lpr MFs (Fig. 5E). Similarly, ex vivo
splenic myeloid cells fromMRL/lprmice exhibited a twofold increase
in active caspase-1 compared with B6 (Fig. 5F). Inflammasome for-
mation was the consequence of lysosomal dysfunction because B6
MFs treated with concanamycin A had high levels of ASC foci and
caspase-1 activation (Fig. 5 D and E). Thus, using dsDNA binding to
AIM2 as a sentry for phagolysosomal membrane permeabilization,
we found that impaired lysosomal degradation of IgG-ICs allows
nuclear antigens to leak into the cytosol. These antigens bind AIM2
coincident with the activation of caspase-1 and the formation of
inflammasomes. Although it would be ideal to assess the contribution
of AIM2 in caspase-1 activation and inflammasome formation in
MRL/lprMFs, the heightened ROS production, heterogeneity of the
ligands contained in the IgG-ICs, and the number of DNA-binding
cytosolic sensors make knockdown of any single sensor unlikely
to have an effect.
To corroborate the idea that antigens leak into the cytosol as a
consequence of diminished phagolysosomal maturation and mem-
brane permeabization, we assessed whether IgG from exogenous
IgG-ICs activated TRIM21, a cytosolic sensor with high affinity for
IgG (45). We found that 4 h after coculture with IgG-ICs, MRL/lpr
MFs showed a twofold increase compared with B6 MFs in fluo-
rophore-tagged IgG bound to TRIM21 (Fig. 6 A and B). The level
of TRIM21-bound IgG in FcγRI−/−MRL/lprMFs was not different
from B6, indicating that similar to nuclear antigen, diminished in-
ternalization of IgG-ICs reduces the amount of IgG reaching the
cytosol. Similarly, coculture of MRL/lpr MFs with IgG-ICs in-
creased the levels of IgH/IgL bound by TRIM21 (Fig. 6A). We do
not believe that the heightened levels of IgG bound to TRIM21 are
a consequence of the 8.8-fold increase in TRIM21 protein levels in
MRL/lpr MFs because FcγRI−/−MRL/lpr MFs also exhibited
heightened levels of TRIM21 (Fig. 6 A and C), and their levels of
IgG bound to TRIM21 were not different from B6 (Fig. 6 A and B).
Thus, elevated TRIM21 may contribute to disease pathology, but it
alone is insufficient unless diminished lysosomal maturation pro-
vides heightened levels of IgG ligand.
TRIM21 is an E3 ligase that possesses two unique functions.
First, it inhibits type 1 IFN production by diminishing interferon
regulatory factor (IRF) protein levels through ubiquitination and
proteasomal degradation. Second, the binding of IgG to TRIM21
stabilizes IRF proteins and activates NF-κB (46, 47), heightening
TLR activation and type 1 IFN production. To assess whether
TRIM21 was activated, we cocultured B6 and MRL/lpr MFs with
IgG-ICs and quantified the nuclear translocation of p65 during
NF-κB activation. Resting MRL/lpr MFs exhibited slightly elevated
nuclear p65 levels; however, this difference was not statistically sig-
nificant. After coculture with IgG-ICs, nuclear translocation of p65
was increased 2.5-fold (Fig. 6 D and E). Loss of FcγRI in MRL/lpr
MFs restored nuclear p65 levels to those in B6 MFs. Further, p65
nuclear translocation was the consequence of failed lysosomal
acidification because concanamycin A-treated B6 MFs stimulated
with IgG-ICs induced a 2.5-fold increase in nuclear p65 (Fig. 6 D
and E). It was possible that NF-κB activation in response to IgG-ICs
resulted from the binding of apoptotic debris to intracellular TLRs.
To assess this possibility, we cocultured MRL/lprMFs with apoptotic
blebs lacking IgG. Like IgG-ICs, apoptotic blebs recycled in MRL/lpr
MF (Fig. S5) possibly because they are opsonized by CRP and enter
cells via FcγRI (48). Despite recycling, apoptotic blebs lacking IgG
did not translocate p65 to the nucleus, indicating that IgG was re-
sponsible for NF-κB activation (Fig. 6 D and E). To determine
whether NF-κB activation in MRL/lpr MFs was the consequence of
TRIM21, we diminished intracellular TRIM21 levels by using
shRNA. Targeting TRIM21 in B6 and MRL/lpr bone marrow-de-
rived macrophages (BMMFs) stably reduced TRIM21 levels com-
pared with transduction with a nontargeting control (Fig. 6F). In
MRL/lpr MFs where TRIM21 levels were diminished, phagocytosis
of IgG-ICs reduced the nuclear p65 levels 3.4-fold, levels comparable
to B6. In contrast, cells transduced with the nontargeting shRNA did
not change nuclear p65 levels (Fig. 6G andH). Thus, the inability to
mature the phagolysosome allows IgG from ICs to leak into the
cytosol and activate TRIM21.
Fig. 3. MRL/lpr MFs fail to mature the lysosome. (A and B) BMMFs were
stimulated with IgG-ICs, and the pH of the maturing phagosomes were
assessed by ratiometric two-photon microscopy; three experiments, three
mice, 10–25 cells. A representative time series of a MF from the indicated
mice (A) with the quantified pH of a single phagosomal acidification event
(arrow) (B) is presented. Ratiometric flow cytometry was used to quantify
the relative phagosomal pH across the entire population of MFs; six exper-
iments, 6–8 mice (C). (D and E) Colocalization of IgG-ICs with LAMP-1 and/or
LC3A was assessed by confocal imaging; three experiments, three mice, 36–
39 cells. A representative image of a MF from the indicated mice (D) and
quantification of IgG-IC colocalization with indicated compartments for all
cells imaged (E) is presented. Error bars = SEM. Student t test, *P ≤ 0.05, **P ≤
0.01, ***P ≤ 0.001. (Scale bars: 5 μm.)
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The activation of TRIM21 by IgG promotes its monoubiquitination,
which acts as a docking site for E2 Ube2N/Ube2V2, inducing
TRIM polyubiquitination and proteasomal degradation (49, 50).
To assess TRIM21 activity in vivo, we quantified the levels of
ubiquitinated TRIM21 in ex vivo splenic myeloid cells from B6 and
MRL/lpr mice. Consistent with TRIM21 activity, we found that
splenic myeloid cells from MRL/lpr mice had 85-fold more mono-
ubiquitinated TRIM21 compared with ex vivo B6 myeloid cells.
Polyubiquitination was not evident (Fig. 6 I and J). IgG was nec-
essary for TRIM21 ubiquitination because ex vivo myeloid cells
from age-matched AID−/−MRL/lpr mice (lack IgG) had signifi-
cantly less ubiquitinated TRIM21 (13.5-fold vs. 85-fold) compared
with B6 myeloid cells. Acute activation of TRIM21 stabilizes IRF3,
whereas chronic activation increases IRF7 levels by activating NF-
κB (46, 47). In ex vivo myeloid cells from MRL/lpr mice, we found
that ubiquitinated TRIM21 was coincident with nuclear trans-
location of p65 and heightened levels of IRF7 protein, but not
with heightened IRF3 (Fig. 6K). The finding that IRF7 protein
levels are selectively increased suggests that TRIM21 activation in
myeloid cells from MRL/lpr mice is not an acute event, but in-
stead, induced by chronic activation through IgG.
Impaired Lysosomal Maturation Results in Heightened Intracellular
TLR Activation. Diminished lysosomal maturation allows IgG
and nuclear antigens to leak into the cytosol and activate innate
sensors. However, a large fraction of IgG-ICs remains inside the
phagosome and is capable of activating TLRs. Coupled with
heightened IRF7 levels from activated TRIM21 (Fig. 6H),
phagosomal TLR ligands could heighten IFNα secretion through
the activation of TLR7 and TLR9 (TLR7/9). To assess whether
the prolonged residency of nuclear antigens within the
phagolysosome activates intracellular TLRs, we quantified
interleukin-1 receptor-associated kinase 1 (IRAK1) levels in MFs
24 h after exposure to IgG-ICs. This time point was sufficient for
B6 MFs to degrade the IgG-ICs, but was before recycling of IgG-
ICs in MRL/lpr MFs (Fig. 4 A and B). We found that MRL/lpr
MFs exposed to IgG-ICs showed a 2.8-fold decrease in IRAK1
levels, consistent with TLR activation (Fig. 7A). Chloroquine, an
acidotropic molecule that binds double- and single-stranded
nucleotides and sterically hinders their binding to TLRs (51),
restored IRAK1 levels supporting that TLR7/9 are activated in
MFs that fail to degrade IgG-ICs. Further, impairing lysosomal
acidification with concanamycin A prevented the degradation of
IgG-ICs in B6 MFs (Fig. 4F) and reduced IRAK1 levels to those
found in MRL/lpr MFs (Fig. 7A). Therefore, the impaired lyso-
somal acidification in MRL/lprMFs is sufficient to heighten TLR
activation in the presence of IgG-ICs.
Formation of the TLR–MyD88–IRAK1 complex downstream
of TLR7/9 promotes phosphorylation and nuclear translocation
of IRF7, resulting in the production of type 1 IFN (52). To assess
whether impaired degradation of IgG-ICs promotes nuclear
translocation of IRF7, we cocultured MRL/lprMFs with IgG-ICs
and found they exhibited a twofold increase in nuclear IRF7
levels (Fig. 7 B and C) that was sustained for 24 h. IgG-ICs did
not localize all IRF proteins to the nucleus as IRF3 remained
cytoplasmic (Fig. 7C). Reducing the lysosomal burden through
loss of FcγRI also reduced the nuclear translocation of IRF7 in
MRL/lpr MFs to levels comparable to B6. These findings were
not an artifact of BMMFs because ex vivo myeloid cells from
MRL/lpr mice also showed a twofold increase in nuclear IRF7,
Fig. 4. IgG-ICs recycle and accumulate on the cell membrane of MRL/lpr
MFs. (A and B) BMMFs from the indicated mice were cultured with IgG-ICs
and examined over time by confocal imaging; four experiments, 3–4 mice,
17–23 cells. A representative image of a MF from the indicated mice (A) and
quantification of IgG-IC colocalization with the cell membrane for all cells
imaged (B) is presented. BMMFs were cultured with GFP-expressing E. coli-ICs
for 1 h. At indicated time points relative levels (to B6+E. coli-IC) of phagocy-
tosed E. coli-ICs (C) and extracellular LPS (relative to B6 1 h; MFI = 6.79–9.32) were
quantified by flow cytometry; three experiments, three mice (D). BMMFs were
cultured with fluorescent IgG-ICs or TNP-ICs for the indicated time. (E) Relative
levels (to B6 0 h) of surface ICs were quantified by flow cytometry at indicated time
points; Left, five experiments, five mice; Right, two experiments, two mice. (F)
BMMFs cultured ± concanamycin A (20 ng/mL) were exposed to fluorescently
tagged IgG-ICs for 72 h and assessed for relative levels (to B6+ICs-Con A) of recycled
IgG-ICs by flow cytometry; 5–6 experiments, 5–6 mice. Error bars = SEM. Student t
test or ANOVA, nd > 0.05, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. (Scale bars: 5 μm.)
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whereas nuclear IRF3 was not elevated (Fig. 7D). Collectively,
the data support a model wherein impaired lysosomal maturation
prolongs phagolysosomal residency of IgG-ICs, facilitating chronic
intracellular activation of IRAK-coupled TLRs.
The inability to degrade IgG-ICs resulted in increased levels of
IRF7 and heightened intracellular TLR activation. Combined, these
events could elevate IFNα secretion (52). To assess this possibility,
we cultured MRL/lpr MFs with IgG-ICs (12, 24 h) and found they
secreted two- and threefold more IFNα (Fig. 7E). The production of
IFNα was a consequence of FcγRI-mediated internalization because
IFNα levels secreted by FcγRI−/−MRL/lprMFs were comparable
to B6. It was also, in part, a consequence of TLR7 and/or
TLR9 because MRL/lpr MFs deficient in TLR7 and TLR9
(TLR7−/−xTLR9−/−/MRL/lpr) secreted 3.2-fold less IFNα com-
pared with MRL/lpr MFs. The data indicate that FcγRI is re-
quired for IFNα secretion by MRL/lpr MFs, and that activation
of TLR7 and/or TLR9 contributes to ∼70% of the IFNα pro-
duced. These findings are consistent with a model wherein di-
minished lysosomal maturation promotes the accumulation of
IgG-ICs in the phagolysosome of MRL/lpr MFs activating TLR7
and/or TLR9 and contributing to IFNα secretion.
Discussion
The mechanism underlying the accumulation of IgG-ICs in the
periphery of SLE patients has been highly debated. A number of
observational studies showed that MFs have intrinsic defects in the
phagocytosis of latex beads, apoptotic cells, IgG-ICs, bacteria, and
yeast (10, 34, 35, 53). Other studies found that phagocytosis is intact,
but the ability to degrade the internalized cargo is impaired (35, 54,
55). We find that lupus-proneMRL/lprMFs phagocytose and traffic
IgG-ICs to lysosomal structures, but that the lysosomal structures
were unable to mature and acidify. As a result, the IgG-ICs were
not degraded and recycled back to the cell membrane. Hemato-
poietic cells from SLE patients have high levels of IgG and nuclear
antigens (32), and they express LAMP1/2 on the cell surface (56).
These findings support the idea that the lysosomal compartment
has trafficked to the membrane and are consistent with our data
showing that MFs from lupus-prone mice accumulated high levels
of nuclear antigens (Fig. 1) as a consequence of the recycling of
undegraded IgG-ICs from the lysosome (Fig. 4). Interestingly IgG-
ICs, apoptotic blebs, and E. coli-ICs recycled to the cell membrane,
whereas TNP-ICs were degraded, suggesting that the size and/or
content of the cargo impairs the lysosome. Alternatively, the op-
sonin coating the incoming apoptotic debris could impact lysosomal
maturation. Combined, these findings could explain the variability
of previous studies aimed at identifying defects in SLE monocytes.
Spontaneous SLE has been linked to alterations in expression
(57) and activation of TLR7/9 (17, 18), dysregulation of the cy-
tosolic sensors p202 and AIM2 (24, 25), and polymorphisms (21)
and heightened expression in TRIM21 (22). We now define that
defective degradation of FcγR-bound cargo in the lysosome is a
critical upstream event that overburdens the phagolysosome.
Prolonged intracellular residency of IgG-ICs promoted the ac-
tivation of TLRs and the permeabilization of the phagolysosomal
membrane, allowing IgG and nuclear antigen to access the cytosol
and activate innate sensors. Other enzymes critical in degrading
nuclear antigens independent of lysosomes including RNase H2
(58), DNase I (59, 60), and DNase III (TREX1) (61) have been
implicated in SLE and may operate in concert with impaired ly-
sosomal maturation to promote autoimmunity. Collectively, our
findings identify the events underlying the accumulation of nuclear
antigens and activation innate sensors that promote autoantibody,
IFNα, and heightened apoptosis in SLE.
Although this study focuses on defining how nuclear antigens
accumulate on MFs, it is important to keep in mind that nuclear
antigen accumulates on DCs and B and T cells (32). Thus, it is
possible that other cells may harbor defects in lysosomal matu-
ration, contributing other disease manifestations. For example,
diminished lysosomal maturation in plasmacytoid dendritic cells
could heighten secretion of IFNα (19), whereas the same defect in
MFs and neutrophils may heighten cell death (62). Further, the
presence of nuclear self-antigens on the cell surface could provide
a source of high avidity antigen that renews BCR signaling and ac-
tivates autoreactive B cells (63), facilitates uptake of TLR ligands
by BCR-mediated endocytosis (17), and positions autoreactive B
cells to further differentiate into memory cells if T-help is
available (64). Thus, the same overarching lysosomal defect may
contribute to the activation of multiple cell types in SLE.
Overlapping autoimmune diseases are common in patients di-
agnosed with SLE including diabetes (65), rheumatoid arthritis (66),
and Sjögren’s syndrome (67). Recent GWAS studies have identified
common genetic polymorphisms including the major histocompat-
ibility complex, TNFAIP3, PTPN22 (68), STAT4 (69), and CD40
(70) that span multiple autoimmune diseases, although their func-
tional role in breaking tolerance is unknown. Our finding that
punctate IgG accumulates on MFs from multiple murine models of
autoimmunity including SLE, diabetes, and rheumatoid arthritis is
interesting because it might reflect that aggregated FcγR/IgG-ICs
are common to multiple autoimmune diseases. Further, the IgG did
not colocalize with high levels of nuclear antigens, suggesting that
the antigens contained in the IgG-ICs might be disease-specific,
thus activating the immune system in different ways. Therefore, the
accumulation of punctate IgG on the surface of MFs from NOD
and K/BxN mice raises the possibility that impaired lysosomal
maturation underlies other autoimmune diseases.
Fig. 5. Impaired lysosomal maturation allows dsDNA to leak into the cytosol and
activate AIM2. BMMFs were stimulated for 4 h with Hoechst-labeled IgG-ICs (A
and B). (A) A representative blot of immunoprecipitated AIM2 (5–8 × 106 cells) is
shown. (B) Relative levels (to B6 untreated) of fluorescent DNA isolated from the
AIM2 immunoprecipitation were quantified by using a fluorescent plate reader;
four experiments, four mice. (C–E) BMMFs were stimulated for 4 h with IgG-ICs ±
concanamycin A (20 ng/mL) and then examined for the formation of ASC foci and
caspase-1 activation by confocal imaging. A representative image of a MF, with
and without ASC foci is presented (C). (Scale bars: 5 μm.) The percentage of cells
with ASC foci for each experiment (D) and relative levels (to B6 untreated) of
caspase-1 activation (E) was quantified for all cells imaged; 10 experiments, 2–10
mice, 63–364 cells. (F) Relative levels (to B6) of caspase-1 activation was measured
in splenic myeloid cells (CD11b+) by flow cytometry; four experiments, 5–9 mice
(≥17 wk; active disease confirmed with kidney H&E). Error bars = SEM. Student t
test or ANOVA, nd > 0.05, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
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Materials and Methods
Mice. C57BL/6 (B6) and MRL/MpJ-Tnfrs6lpr/J (MRL/lpr; JAX mice Stock 000485)
colonies were maintained in an accredited animal facility at University of
North Carolina at Chapel Hill. Experimental methods were approved by the
University of North Carolina’s Institutional Animal Care and Use Committee
(IACUC). NZM2410 mice (71) were obtained from Gary Gilkeson (mice were
12–22 wk of age; Medical University of South Carolina, Charleston, SC),
AID−/−MRL/lprmice (72) fromMarilyn Diaz, National Institute of Environmental
Health Sciences (NIEHS), Research Triangle Park, NC, NOD mice from Roland
Tisch (blood glucose levels > 500 mg/dL; University of North Carolina), K/BxN
mice (73) from Christophe Benoist (clinical score = 10, ankle thickening = 3.85–
3.95 mm; Harvard Medical School, Boston), and C57BL/6-Tg(UBC-GFP)30Scha/J
(GFP-expressing) mice (74) from Bill Goldman, University of North Carolina.
We generated FcγRI−/−MRL/lpr mice by backcrossing FcγRI−/−/C57BL/6 mice to
MRL/lpr mice for 10 generations. TLR7−/−/MRL/lpr and TLR9−/−/MRL/lpr mice
were reconstituted from sperm (75) and then intercrossed to generate
TLR7−/− × TLR9−/−/MRL/lpr mice.
Reagents. Antibodies specific for LAMP1 and CD11b were purchased from BD
Biosciences; LC3A from Cell Signaling; goat anti-rabbit IgG and rabbit anti-
goat IgG fromMolecular Probes; AIM2, ASC, TRIM21, p65, IRAK1, IRF3, and IRF7
from Santa Cruz Biotechnologies; anti-IgG from Jackson ImmunoResearch; and
anti-LPS (Escherichia coli J5) from Thermo Scientific. Concanamycin A and
chloroquine diphosphate salt were purchased from Sigma-Aldrich, Immuno-
gold conjugate EM streptavidin from BB International, and TNP20KLH from
Biosearch Technologies. Antibodies specific to Smith (Sm; 2.12.3), nucleosome
(PL2-3), CD16/32 (2.4G2), and TNP (Hy1.2) were purified from hybridoma culture
supernatant by using protein G-Sepharose (GE Healthcare) then left unlabeled
or conjugated with Alexa Fluor according to the manufacturer’s instructions
(Molecular Probes). Fluorescent molecules LysoSensor, dihydrorhodamine 123,
and CellMask were purchased fromMolecular Probes, and FAM-FLICA caspase-1
assay kit from ImmunoChemistry Technologies. LI-COR blocking buffer, IRDye680-,
and IRDy800-conjugated antibodies (anti-rabbit, anti-mouse, anti-goat) were
purchased from LI-COR Biosciences. To differentiate BMMFs, we generated L929
cell (European Collection of Cell Cultures) supernatant by plating 2.5 × 105 cells
into a T150 flask with 50 mL of D10 media [DMEM with 10% (vol/vol) FBS, 1 mM
sodium pyruvate, 50 μg/mL gentamicin, 100 μg/mL Pen/Strep, 2 mM L-glutamine,
50 nM βmercaptoethanol (β-ME)]. After 12 d, supernatant was collected
and filtered.
Splenocyte Isolation. Spleens from mice were ground between frosted glass
slides and filtered through a 70-μm filter to create a single-cell suspension in
PBS. Pelleted cells were resuspended in 2 mL of NH4Cl2 (0.154 M) for 7 min at
room temperature, and then filtered through a 40-μm filter into PBS. Cells
were pelleted, then resuspended at 108 cells/mL and used for experiments.
Alternatively, CD11b+ splenocytes were purified per manufacturer’s instruc-
tions (Stemcell Technologies).
BMMF Cultures. Single-cell suspensions of bone marrow were prepared from
the tibias and femurs of mice. Mononuclear cells were isolated by using
Lympholyte SeparationMedium (CEDARLANE Laboratories), plated in a 60-mm
Petri dish with 6 mL ofMF differentiation media [D10media with 10% (vol/vol)
L-cell supernatant], and cultured overnight (37 °C, 5% CO2). Nonadherent cells
were plated into nontissue culture-treated 100-mm Petri dishes (0.75–1 mL
cells per Petri dish) with 7 mL of fresh MF differentiation media. To promote
MF differentiation, cells were incubated for 6 d (37 °C, 5% CO2) with an ad-
ditional 5 mL of MF differentiation media being added on day 4. The resulting
BMMFs were removed from the dish by washing with ice cold PBS. BMMF
cultures were 98% CD11b+, I-Alo, and B7.2lo.
Formation of Immune Complexes.
IgG-ICs. Single-cell suspensions of thymocytes were prepared from 5- to 8-wk
mice, irradiated (600 rads), and cultured 16–18 h in 10 mL of PBS (37 °C, 5%
CO2). Apoptotic thymocytes were centrifuged for 5 min (350 × g), and the
supernatant containing apoptotic debris was incubated with autoantibodies
(2.12.3 or PL2-3) on ice for 30 min (6.67 μg of Ab/1 mL of supernatant). IgG-ICs
were pelleted (160,000 × g) at 4 °C for 45 min and resuspended in 250 μL of R10
media [RPMI with 10% (vol/vol) FBS, 1 mM sodium pyruvate, 50 μg/mL genta-
micin, 100 μg/mL Pen/Strep, 2 mM L-glutamine, 50 nM β-ME].
Fig. 6. Impaired lysosomal maturation allows IgG to
leak into the cytosol and activate TRIM21. BMMFs
were stimulated with fluorescently tagged IgG-ICs
(4 h), and TRIM21 was immunoprecipitated (5–8 ×
106 cells) (A–C). (A) Representative blots of TRIM21
and IgH/IgL chains is shown. (B) Relative levels (to B6
untreated) of fluorescent IgG isolated from TRIM21
immunoprecipitates; seven experiments, seven mice.
(C) Relative levels (to B6 untreated) of immunopre-
cipitated TRIM21 was quantified by densitometry;
three experiments, three mice. (D and E) Nuclear
translocation of p65 subunit of NF-κB was quantified
in BMMFs stimulated for 4 h with IgG-ICs or apo-
ptotic debris (lacking IgG),± concanamycin A (20 ng/mL);
six experiments, 3–6 mice, 16–57 cells. Representa-
tive image of p65 nuclear localization in MFs from
the indicated mice (D) and quantification of p65
colocalization with the nucleus of all cells imaged (E)
is presented. (F–H) BMMFs were transduced with
lentivirus expressing indicated shRNA. Relative levels
of TRIM21 (to B6+nontargeting; MFI = 2.57–7.25) in
transduced cells (GFP+) were quantified by flow
cytometry; three experiments, three mice (F), and
nuclear translocation of the p65 subunit of NF-κB
was quantified in transduced cells (GFP+) stimulated
for 4 h with IgG-ICs; two experiments, two mice, 20–
22 cells (G and H). Localization of p65 in MFs from
the indicated mice (G) and quantification of p65
colocalization with the nucleus (H) is presented.
(I and J) Ubiquitin was immunoprecipitated from
splenic myeloid cells (CD11b+; 35 × 106 cells) and
immunoblotted for TRIM21; two experiments, 4–5
mice (≥17 wk). A representative blot of TRIM21 fol-
lowing immunoprecipitation of ubiquitin (I) and
relative levels (to B6) of ubiquitinated TRIM21 was
quantified by densitometry (J) is presented. Splenic myeloid cells (CD11b+) were analyzed for relative levels (to B6) of IRF7 and IRF3 by confocal microscopy; two
experiments, two mice, 10–28 cells (K). Error bars = SEM. Student t test or ANOVA, nd > 0.05, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001. (Scale bars: 5 μm.)
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TNP-ICs. TNP20-KLH was incubated with anti-TNP antibody (Hy1.2) on ice for
30 min (30 μg of Ab/1 μg of TNP-KLH). TNP-ICs were pelleted (160,000 × g) at
4 °C for 45 min and resuspended in 200 μL of R10 media (as above).
E. coli-ICs. GFP-expressing E. coli (76) was incubated with anti-LPS at room
temperature for 2 h (1.5 μg/6.25 × 106 E. coli) in the presence of gentamicin
(10 μg/1 mL). E. coli-ICs were cultured with BMMFs [multiplicity of infection
(MOI) = 25].
Fluorescent Microscopy. All confocal microscopy used a Zeiss 710 confocal
microscope with a 63× 1.4 N.A. (oil) PLAN APO lens and Zeiss Zen software.
All two-photon microscopy used an Olympus FlouView FV1000MPE multi-
photon microscope with a 25× 1.05 N.A. (water) XLPlan N lens and Olympus
FluoView software. Cells were randomly selected from many fields of view
across the coverslip. Excluded cells were clumped (5–15% of the cells), un-
healthy (5–15% of the cells, determined by Hoechst staining), or improperly
stained (< 2% of the cells). Data were analyzed by using ImageJ.
IgG-IC/apoptotic bleb localization. BMMFs were cultured in the presence of
Alexa488-labeled IgG-ICs or GFP-expressing apoptotic debris in R10 media (as
above). After 2 h, the media was aspirated and cells were cultured in fresh R10
media. CellMask and Hoechst 33342 were introduced to BMMFs 15 min before
fixation at indicated time points. Cells were fixed in 2% (vol/vol) para-
formaldehyde in PBS and transferred to 4 °C for 15min. Cells were resuspended
in FluorSave and loaded onto coverslips for imaging. The membrane locali-
zation of IgG-ICs or apoptotic debris was quantified by calculating the Man-
der’s coefficient of colocalization (colocalized pixels/total fluorescent pixels).
Two-photon microscopy/pH quantification. Two hours before imaging, BMMFs
were incubated (37 °C, 5% CO2) on a glass bottom Petri dish (MatTek)
in rhodamine-free R10 media (as above). Immediately after adding 40 μL
of IgG-ICs and LysoSensor (2 mg/mL), cells were imaged for 1 h. The dye
was excited by using two-photon excitation (710 nm), and emissions at
420–460 nm and 495–540 nm were quantified. The ratio of the emission
channels were used to determine the pH of the vesicles by using a stan-
dard curve generated by exciting LysoSensor with medium of varying pH.
ASC localization/caspase-1 activation. BMMFs were cultured with FAM-FLICA
caspase-1 (5 μM) for 20 min before indicated time points. At the indicated
time points, cells were washed, fixed with 2% (vol/vol) paraformaldehyde in
PBS, and incubated at 4 °C for 15 min. Cells were blocked in 2.4G2 for 30 min
at 4 °C in FACS media [2% (vol/vol) FBS, 0.02% NaN3 in PBS] then stained
with an anti-ASC and Hoechst 33342 (1 μg/mL) in permeabilization buffer
(PBS with 0.05% Saponin and 0.5% BSA) for 30 min at 4 °C. Cells were
washed, stained with goat anti-rabbit IgG-Alexa 647 in permeabilization
buffer for 30 min at 4 °C, washed, costained with anti-CD11b in FACS media
for 30 min at 4 °C, washed, resuspended in FluorSave, and loaded onto
coverslips for imaging. Cells with ASC foci were counted and expressed as a
percentage of the total cells. Total caspase-1 activation per cell was quan-
tified (background fluorescence subtracted) and normalized by cell area.
LAMP1/LC3A, IRF, and p65 localization. BMMFs, or splenic myeloid cells (CD11b+)
purified by positive selection, were prepared as described for ASC localiza-
tion/caspase-1 activation except cells were stained for LAMP1 and LC3A,
IRF3, IRF7, or p65. The nuclear localization of IRF or p65 was quantified by
calculating the Mander’s coefficient of colocalization (colocalized pixels/
total fluorescent pixels). Total IRF protein in myeloid cells was quantified by
determining the total fluorescent pixels (normalized to cell area).
Ex vivo surface stain. Ex vivo splenic cells were fixed in 2% (vol/vol) para-
formaldehyde in PBS and incubated for 15 min at 4 °C. Cells were blocked in
2.4G2 for 30 min at 4 °C in FACs media (as above), washed, stained with anti-Sm
(2.12.3) and anti-IgG in FACSmedia for 30 min at 4 °C, washed, stained with anti-
CD11b in FACS media for 30 min at 4 °C, and washed. Cells were resuspended in
FluorSave and loaded onto coverslips for microscopic imaging. The membrane
localization of IgG with Sm was quantified by calculating the Mander’s co-
efficient of colocalization (colocalized pixels/total fluorescent pixels).
Flow Cytometry. All flow cytometry used an 18-color Becton Dickinson LSR II
Flow cytometer, and data were acquired by using Becton Dickinson FACSDiva
8.0.1 software.
Recycling of IgG-IC and TNP-IC using flow. BMMFs were incubated (37 °C, 5% CO2)
with 40 μL of Alexa488-labeled IgG-ICs or TNP-ICs in R10 media (as above). To
quantify surface-bound ICs at 0 h, phagocytic uptake was impaired by culturing
with IgG-ICs on ice for 2 h. This protocol was sufficient to allow the ICs to bind
to the surface of the cell but not be phagocytosed. For all other time points,
cells were incubated (37 °C, 5% CO2) for 2 h, then media was replaced to
remove all unbound ICs. At indicated time points, cells were blocked in 2.4G2
for 30min on ice in FACS media (as above), washed, and split into two samples.
One sample was incubated with an anti-Alexa488 antibody (quenches
Alexa488 fluorescence), whereas the other sample was left in FACS media for
Fig. 7. Impaired lysosomal maturation promotes intracellular TLR activa-
tion and IFNα secretion. (A) BMMFs (1–1.5 × 106 cells) were stimulated for 24 h
with IgG-ICs ± hydroxychloroquine (50 μg/mL) or ± concanamycin A (20 ng/
mL); five experiments, 3–5 mice. IRAK1 was immunoblotted from whole cell
lysates and relative levels (to B6 untreated) of IRAK1 were quantified by
densitometry. A representative IRAK1 blot is shown. (B and C) BMMFs were
stimulated with IgG-ICs (4 h), and the nuclear translocation of IRF7 or IRF3 was
quantified by confocal microscopy; four experiments, 3–4 mice, 20–42 cells.
(Scale bars: 5 μm.) A representative image of a MF from the indicated mice (B)
and quantification of IRF colocalization with the nucleus of all cells imaged (C)
is presented. (D) Splenic myeloid cells (CD11b+) were analyzed for nuclear IRF7
and IRF3 by confocal microscopy; two experiments, two mice (≥17 wk; active
disease confirmed with kidney H&E), 10–28 cells. Supernatants from IgG-IC
stimulated BMMFs were collected at the indicated time points and cocultured
with WISH cells. Relative levels (to B6 0 h) of IFIT message as an indirect
measure of IFNα were quantified by RT-PCR (E); three experiments, three mice.
Error bars = SEM. Student t test or ANOVA, nd > 0.05, *P ≤ 0.05, **P ≤ 0.01,
***P ≤ 0.001.
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30 min on ice. Both samples were washed and fixed with 2% paraformaldehyde
and incubated at 4 °C for 15 min. Surface-bound IgG-ICs were calculated by
subtracting the mean fluorescence intensity (MFI) of the quenched sample (in-
tracellular IgG-ICs) from the MFI of the unquenched sample (total IgG-ICs).
Values were normalized to B6 0 h.
E. coli-IC recycling flow. BMMFs were incubated (37 °C, 5% CO2) with E. coli-ICs
(MOI = 25) in R10 media (as above). Cells were incubated (37 °C, 5% CO2) for
1 h, then media was replaced to remove all unbound ICs. At indicated time
points, cells were blocked in 2.4G2 for 30 min on ice in FACS media (as above),
washed, and incubated with Alexa647-labeled anti-LPS in FACS media for 30 min
on ice. Samples were washed and fixed with 2% paraformaldehyde, and then
incubated at 4 °C for 15 min. Cells were resuspended in FACS media, and
the levels of phagocytosed E. coli-ICs and surface LPS were quantified by
flow cytometry. MFI values for phagocytosed E. coli-ICs were normalized
to B6+E. coli-ICs. MFI for surface LPS was normalized to an isotype control.
Ratiometric flow cytometry. BMMFs were incubated (37 °C, 5% CO2) for 2 h
before the addition of 40 μL of IgG-ICs in R10 media (as above). To quantify a
cell that has not acidified, concanamycin A (20 ng/mL) was introduced to one
sample from each cell type 2 h before addition of IgG-ICs and left on the cells
throughout the experiment. IgG-ICs and LysoSensor (2 mg/mL) were in-
troduced for 30 min, aspirated, and replaced with fresh rhodamine-free R10
media. Cells were incubated until indicated time points and analyzed by
flow cytomualifiedetry. The dye was excited with a UV laser (355 nm). Rel-
ative pH was quantified by ratioing the MFIs from the emission channels
(450/20 nm, 585/42 nm) (normalized to concanamycin A control).
Ex vivo surface stain. Ex vivo splenic cells were prepared as described for “Ex
vivo surface stain” in the “Fluorescent Microscopy” section. Cells were
resuspended in FACS media, and the MFI of the surface Sm and IgG were
determined by flow cytometry and normalized to an isotype control.
Ex vivo caspase-1 activation. Ex vivo splenic cells were cultured with FAM-FLICA
caspase-1 (5 μM) for 20 min before fixation. Cells were fixed in 2% para-
formaldehyde and incubated for 15 min at 4 °C. Cells were washed, stained with
anti-CD11b in FACS media for 30 min at 4 °C, and washed. Cells were resus-
pended in FACS media, and the MFI of the surface Sm was determined by flow
cytometry and normalized to an isotype control. Values are normalized to B6.
TRIM21 flow cytometry. Following viral transduction, BMMFs were fixed with
2% (vol/vol) paraformaldehyde in PBS, then incubated at 4 °C for 15 min. Cells
were blocked in 2.4G2 for 30 min at 4 °C in FACS media (as above), washed,
and stained with anti-TRIM21 in permeabilization buffer (as above) for 30 min
at 4 °C. Cells were washed, stained with rabbit anti-goat IgG-Alexa 647 in
permeabilization buffer for 30 min at 4 °C, washed, and resuspended in FACS
media. The MFI of the TRIM21 were determined by flow cytometry and normal-
ized to an isotype control.
Cryo-Electron Microscopy. BMMFs were incubated with 40 μL of gold-labeled
IgG-ICs for 2 h (37 °C, 5% CO2). Suspensions of MFs were loaded into gold
planchettes (model 16706897; well size 1.2 mm × 200 μm), placed in high pres-
sure-freeze (HPF) holders, and torqued to make a tight seal. Each sample was
placed in a HPF chamber where the pressure was increased with cyclohexane to
∼2,000 bars just milliseconds before a blast of liquid nitrogen cooled the as-
sembly at approximately 18,000 °C/sec by using a Leica EM PACT HPF. The
pressure and cooling curves were recorded and examined after each run to
ensure consistency. Frozen samples were transferred to liquid nitrogen for
storage. Samples were then transferred to vials containing 2% osmium tetroxide
in dry acetone cooled in liquid nitrogen. The vials were transferred cold to a
chamber at −90 °C in a Leica EM AFS freeze substitution device, where samples
remained for 72 h. Samples were warmed automatically by using a program that
increased the temperature to −20 °C at 4 °C/h, held at −20 °C for 10 h, then
warmed at 4 °C/h to 20 °C. The warmed fixed samples were processed for
transmission electron microscopy (TEM) by washing with fresh acetone and
replacing the acetone with propylene oxide, embedding in epon (EMS EMbed-
812), and hardening at 60 °C. Thin sections, 60–70 nm thick, were cut with a
diamond knife on a Leica Ultracut UTC and stained with uranyl acetate and lead
citrate. Stained thin sections were examinedwith an FEI Tecnai T12 G2 TEM at 80
kV by using a Gatan 794 digital camera and Gatan Digital Montage software to
prepare up to 5 × 5 montages of selected MFs imaged at 6,000–30,000×.
Immunoprecipitation and Western Blot. Lysates were prepared by the addition
of lysis buffer containing 1%CHAPS, 150mMNaCl, 10mM Tris (pH 7.5), 2 mM
sodium orthovanadate, 1 mM PMSF, 0.4 mM EDTA, 10 mM NaF, and 1 μg/mL
each of aprotinin, leupeptin, and α1-antitrypsin (in water) to cell pellets.
Lysates were held on ice for 10 min followed by the removal of particulate
material by centrifugation at 12,000 × g for 10 min at 4 °C.
Antibodies used in the immunoprecipitations were conjugated to
cyanogen bromide-activated Sepharose 4B according to manufacturer’s in-
structions (Amersham Pharmacia Biotech). Approximately 2 μg of precipitating
antibodies was incubated with 1.5 × 106 cell equivalents of cleared lysate for
1 h at 4 °C. Immunoprecipitates were washed twice with lysis buffer, resus-
pended in reducing SDS/PAGE sample buffer, and fractionated by 10% SDS/
PAGE. Separated proteins were transferred to Immobilon-FL membranes.
Membranes were blocked in LI-COR Blocking Buffer, incubated with the var-
ious immunoblotting Abs followed by the appropriate fluorophore-conju-
gated secondary Abs. Immunoreactive proteins were detected by using a
LI-COR Odyssey infrared imaging system with Odyssey 3.0 software.
Plate Reader. All analysis used a Tecan M200 fluorescence plate reader.
ROS assay. BMMFs were incubated (37 °C, 5% CO2) for 2 h before the addition of
40 μL of IgG-ICs in R10media (as above) in an opaque 96-well plate. Thirtyminutes
before indicated time points, dihydrorhodamine 123 (3 μg/mL) was added to each
well. At the indicated time points, cells were washed, fixed with 2% para-
formaldehyde, and transferred to 4 °C for 15 min. Wells were analyzed in
FACS media (as above). Each sample had an N-acetylcysteine–treated control
(1 mM). Fluorescent readings were normalized toN-acetylcysteine–treated B6MFs.
Immunoprecipitation assay. All beads from immunoprecipitation sample were
added to a single well in an opaque 96-well plate in PBS. Wells were analyzed
for Hoechst-labeled dsDNA (AIM2 immunoprecipitation) and Alexa647-labeled
IgG (TRIM21 immunoprecipitation). All fluorescent readings were normalized
to the background fluorescence of beads alone.
BMMF Transduction. BMMFs were prepared as described above. On day 3, cells
in a 24-well low cluster plate were transduced with lentiviral particles
(SMARTvector Lentiviral mouse TRIM21 mCMV-TurboGFP shRNA; MOI = 40;
polybrene = 5 μg/mL) according to manufacturer’s instructions (Dharmacon).
Separate cells were transduced with SMARTvector Nontargeting mCMV-
TurboGFP control particles. On days 5 and 6, culture medium was replen-
ished with an additional 750 μL of macrophage differentiation media. Stably
transduced cells expressed GFP by day 6 (8–20% of the culture).
WISH Cell IFNα Assay. WISH cells (product no. CCL-25; American Type Culture
Collection) were grown in minimum essential medium supplemented with
L-glutamine (2 mM), Hepes (20 mM), penicillin (100 units/mL), streptomycin
(100 μg/mL), and 10% (vol/vol) FBS (37 °C, 5% CO2). To measure IFNα levels,
we quantified mRNA of IFN-regulated genes as described (77). WISH cells
were plated (0.5 × 105 cells per 0.1 mL) in 96-well flat bottom plates and
cultured with media alone, recombinant mouse IFNα (100 units/mL; Bio-
Source International), or BMMF supernatant (200 μL) for 24 h (37 °C, 5%
CO2). WISH cells were lysed, RNA extracted (RNeasy Mini Kit; Qiagen), and
cDNA prepared from 500 ng of RNA (iScript c-DNA Synthesis Kit; Bio-Rad
Laboratories). The cDNA obtained from each sample was diluted 1:60, and 2 μL
was amplified in a 20-μL real-time quantitative PCR by using 10 mM forward
and reverse primers and the 2× iQ SYBR Green Supermix (Roche Laboratories).
Statistics. Error bars represent the SEM. For the TIRF assay, error bars rep-
resent the variation between individual IgG-ICs on the surface of the cell. For
other microscopy-based experiments, the error bars represent the variation
between cells. In all other assays, the error bars represent the variation
between mice. All P values were calculated by using an unpaired t test (two
groups) or an ANOVA (groups ≥ 3). Significance is indicated on the graphs
(“nd” P > 0.05, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001).
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